313 related articles for article (PubMed ID: 35156888)
1. Biologics in Pediatric Inflammatory Bowel Disease.
Kleinhenz J; Wagner E
Pediatr Ann; 2022 Feb; 51(2):e77-e81. PubMed ID: 35156888
[TBL] [Abstract][Full Text] [Related]
2. Management of inflammatory bowel disease beyond tumor necrosis factor inhibitors: novel biologics and small-molecule drugs.
Na SY; Kim YS
Korean J Intern Med; 2022 Sep; 37(5):906-919. PubMed ID: 35945034
[TBL] [Abstract][Full Text] [Related]
3. Beyond diagnosis: investigating hospital referral impact on biological treatment initiation, hospital admission, and surgery patterns in inflammatory bowel disease - a Danish population based study.
Larsen L; Olesen AE; Nayeb AB; Grøntved S; Krarup AL
Scand J Gastroenterol; 2024 Jun; 59(6):690-697. PubMed ID: 38567864
[TBL] [Abstract][Full Text] [Related]
4. [4th Congress of ECCO (5-7 February 2009, Hamburg (Germany). (The European Crohn's and Colitis Organization)--Inflammatory bowel diseases 2009)].
Baryshnikov EN; Kniazev OV
Eksp Klin Gastroenterol; 2009; (3):158-60. PubMed ID: 19928013
[TBL] [Abstract][Full Text] [Related]
5. Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease.
Hyams JS; Dubinsky MC; Baldassano RN; Colletti RB; Cucchiara S; Escher J; Faubion W; Fell J; Gold BD; Griffiths A; Koletzko S; Kugathasan S; Markowitz J; Ruemmele FM; Veereman G; Winter H; Masel N; Shin CR; Tang KL; Thayu M
Gastroenterology; 2017 Jun; 152(8):1901-1914.e3. PubMed ID: 28193515
[TBL] [Abstract][Full Text] [Related]
6. The risk for opportunistic infections in inflammatory bowel disease with biologics: an update.
Borman ZA; Côté-Daigneault J; Colombel JF
Expert Rev Gastroenterol Hepatol; 2018 Nov; 12(11):1101-1108. PubMed ID: 30277409
[TBL] [Abstract][Full Text] [Related]
7. [Inflammatory bowel disease: an overview].
Herrlinger K
Med Monatsschr Pharm; 2013 Nov; 36(11):402-8; quiz 409. PubMed ID: 24640117
[TBL] [Abstract][Full Text] [Related]
8. Updates in therapeutic drug monitoring in inflammatory bowel disease.
Lodhia N; Rao S
World J Gastroenterol; 2022 Jun; 28(21):2282-2290. PubMed ID: 35800180
[TBL] [Abstract][Full Text] [Related]
9. Safety of perioperative treatment with biologics in patients with inflammatory bowel disease undergoing bowel surgery: Experience from a large urban center.
Schnitzler F; Tillack-Schreiber C; Szokodi D; Braun I; Tomelden J; Sohn M; Bader F; Waggershauser C; Ochsenkühn T
PLoS One; 2024; 19(1):e0290887. PubMed ID: 38236926
[TBL] [Abstract][Full Text] [Related]
10. Role of the combination of biologics and/or small molecules in the treatment of patients with inflammatory bowel disease.
Balderramo D
World J Gastroenterol; 2022 Dec; 28(47):6743-6751. PubMed ID: 36620336
[TBL] [Abstract][Full Text] [Related]
11. Orphan patients with inflammatory bowel disease - when we treat beyond evidence.
Privitera G; Pugliese D; Lopetuso LR; Scaldaferri F; Papa A; Rapaccini GL; Gasbarrini A; Armuzzi A
World J Gastroenterol; 2021 Dec; 27(47):8047-8057. PubMed ID: 35068853
[TBL] [Abstract][Full Text] [Related]
12. Effect of Biologics on the Risk of Advanced-Stage Inflammatory Bowel Disease-Associated Intestinal Cancer: A Nationwide Study.
Seishima R; Okabayashi K; Ikeuchi H; Uchino M; Futami K; Noguchi T; Ohge H; Iseki Y; Watanabe K; Itabashi M; Okamoto K; Toiyama Y; Ogino T; Nakamura M; Yamada K; Wakai T; Sato Y; Kimura H; Takahashi K; Hida K; Kinugasa Y; Ishida F; Okuda J; Daito K; Koyama F; Ueno H; Yamamoto T; Yamamoto S; Hanai T; Maemoto A; Arakaki J; Komori K; Akagi Y; Shida D; Yamaguchi S; Matsuda K; Maeda K; Noake T; Nezu R; Sasaki S; Hasegawa J; Sunami E; Kanemitsu Y; Katsumata K; Uehara K; Kiyomatsu T; Suto T; Kazama S; Yamada T; Goi T; Ishihara S; Ajioka Y; Sugihara K
Am J Gastroenterol; 2023 Jul; 118(7):1248-1255. PubMed ID: 36622356
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory Bowel Disease-Unclassified in Children: Diagnosis and Pharmacological Management.
D'Arcangelo G; Aloi M
Paediatr Drugs; 2017 Apr; 19(2):113-120. PubMed ID: 28150131
[TBL] [Abstract][Full Text] [Related]
14. Preoperative Considerations in Inflammatory Bowel Disease.
McKenna NP; Lightner AL
Surg Clin North Am; 2019 Dec; 99(6):1083-1094. PubMed ID: 31676049
[TBL] [Abstract][Full Text] [Related]
15. Biologic Use Patterns and Predictors for Non-persistence and Switching of Biologics in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study.
Jung YS; Han M; Park S; Cheon JH
Dig Dis Sci; 2020 May; 65(5):1436-1444. PubMed ID: 31677070
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic Disease Activity and Biologic Therapy Are Independent Predictors of Suboptimal Bowel Preparation in Patients with Inflammatory Bowel Disease Undergoing Colonoscopy.
Kumar A; Shenoy V; Buckley MC; Durbin L; Mackey J; Mone A; Swaminath A
Dig Dis Sci; 2022 Oct; 67(10):4851-4865. PubMed ID: 35624326
[TBL] [Abstract][Full Text] [Related]
17. Biosimilars in inflammatory bowel disease.
Talathi S; Baig KRKK
J Dig Dis; 2020 Nov; 21(11):610-620. PubMed ID: 32920972
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of inflammatory bowel disease in the Australian general practice population: A cross-sectional study.
Busingye D; Pollack A; Chidwick K
PLoS One; 2021; 16(5):e0252458. PubMed ID: 34043730
[TBL] [Abstract][Full Text] [Related]
19. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
[TBL] [Abstract][Full Text] [Related]
20. Changes in surgery rates among hospitalized patients with inflammatory bowel disease in Japan from 2015 to 2019: A nationwide administrative database analysis.
Yoshida S; Imai S; Fushimi K
J Gastroenterol Hepatol; 2024 Feb; 39(2):272-279. PubMed ID: 37961024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
